Bupropion as an Adjunct to the Nicotine Patch Plus CBT
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Existing and new pharmacotherapies along with prevention efforts are key to improving smoking
cessation rates and reducing the premature morbidity and mortality associated with tobacco
use. A number of individuals suffer from both nicotine dependence and depression. The purpose
of this study is to determine the effectiveness of bupropion used in combination with the
nicotine replacement patch and cognitive behavior therapy (CBT) in treating nicotine
dependent individuals also diagnosed with depression.